Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,772,561
-
Share change
-
+79,235
-
Total reported value
-
$145,496,081
-
Put/Call ratio
-
172%
-
Price per share
-
$9.22
-
Number of holders
-
76
-
Value change
-
+$1,323,762
-
Number of buys
-
35
-
Number of sells
-
42
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q4 2019
As of 31 Dec 2019,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,772,561 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., INGALLS & SNYDER LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.